Enzaplatovir
Modify Date: 2024-01-02 16:53:04
Enzaplatovir structure
|
Common Name | Enzaplatovir | ||
|---|---|---|---|---|
| CAS Number | 1323077-89-9 | Molecular Weight | 377.397 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 663.0±55.0 °C at 760 mmHg | |
| Molecular Formula | C20H19N5O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 354.8±31.5 °C | |
Use of EnzaplatovirEnzaplatovir (BTA-585, BTA-C585) is an orally bioavailable RSV fusion protein inhibitor for the treatment of respiratory syncytial virus infections. RSV Infection Phase 2 Discontinued |
| Name | enzaplatovir |
|---|---|
| Synonym | More Synonyms |
| Description | Enzaplatovir (BTA-585, BTA-C585) is an orally bioavailable RSV fusion protein inhibitor for the treatment of respiratory syncytial virus infections. RSV Infection Phase 2 Discontinued |
|---|---|
| References | References View Related Products by Target RSV RSV Infection |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 663.0±55.0 °C at 760 mmHg |
| Molecular Formula | C20H19N5O3 |
| Molecular Weight | 377.397 |
| Flash Point | 354.8±31.5 °C |
| Exact Mass | 377.148804 |
| LogP | -0.43 |
| Vapour Pressure | 0.0±2.0 mmHg at 25°C |
| Index of Refraction | 1.731 |
| OZ40XB915E |
| UNII:OZ40XB915E |
| enzaplatovir |
| 1H,5H-Imidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5-one, 2,3,10,10a-tetrahydro-1-[(3-methyl-4-isoxazolyl)carbonyl]-10a-(6-methyl-3-pyridinyl)-, (10aR)- |
| (10aR)-1-[(3-Methyl-1,2-oxazol-4-yl)carbonyl]-10a-(6-methyl-3-pyridinyl)-2,3,10,10a-tetrahydro-1H,5H-imidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5-one |